Purchases and Sales Made in Q3 2022 in Logic Bio Therapeutics, Inc. (LOGC)
This table provides information about the institutional ownership of Logic Bio Therapeutics, Inc. (LOGC) during Q3 2022. The information is specifically focused on institutions that hold shares of LogicBio Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
186K+ 59.36% |
$54K - $125K
|
500K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
116KNew |
$33.6K - $77.7K
|
116K
$0
|
|
|
Nov 07, 2022
Q3 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
80.8KNew |
$23.4K - $54.1K
|
80.8K
$0
|
|
|
Nov 04, 2022
Q3 2022
|
Prudential Financial Inc
Newark, NJ |
BUY
|
- |
34.6K+ 54.06% |
$10K - $23.2K
|
98.6K
$0
|
|
|
Nov 04, 2022
Q3 2022
|
Simplex Trading, LLC
|
BUY
|
- |
600+ 1500.0% |
$174 - $402
|
640
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
24New |
$6.96 - $16.1
|
24
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
5+ 0.41% |
$1.45 - $3.35
|
1.23K
$0
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1- 0.01% |
$0.29 - $0.67
|
10.7K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-3.51K- 2.01% |
$1.02K - $2.35K
|
171K
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-10.3K- 46.74% |
$3K - $6.92K
|
11.8K
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-11.4K- 53.71% |
$3.31K - $7.66K
|
9.85K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-16K- 22.89% |
$4.64K - $10.7K
|
53.9K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-137K- 32.62% |
$39.7K - $91.7K
|
283K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-312K- 69.19% |
$90.6K - $209K
|
139K
$0
|